CONMED Corporation (CNMD)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 132,424 | 131,740 | 98,593 | 82,349 | 64,459 | 57,972 | 88,285 | -93,738 | -80,582 | -82,722 | -113,924 | 67,657 | 62,542 | 62,238 | 54,140 | 13,450 | 9,517 | 310 | 430 | 33,525 |
| Total assets | US$ in thousands | 2,306,250 | 2,315,740 | 2,285,620 | 2,309,260 | 2,300,020 | 2,325,680 | 2,322,720 | 2,320,120 | 2,297,590 | 2,292,040 | 2,072,260 | 1,785,720 | 1,766,020 | 1,754,090 | 1,761,970 | 1,746,610 | 1,751,670 | 1,743,130 | 1,723,910 | 1,750,970 |
| ROA | 5.74% | 5.69% | 4.31% | 3.57% | 2.80% | 2.49% | 3.80% | -4.04% | -3.51% | -3.61% | -5.50% | 3.79% | 3.54% | 3.55% | 3.07% | 0.77% | 0.54% | 0.02% | 0.02% | 1.91% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $132,424K ÷ $2,306,250K
= 5.74%
CONMED Corporation's return on assets (ROA) has exhibited fluctuating trends over the past few years. The ROA was relatively low in the middle of 2020, hovering around 0.02%. However, it started to improve towards the end of the year and continued to increase through the first half of 2021, reaching 3.07% by June 2021.
In the subsequent quarters, CONMED Corporation's ROA remained relatively stable at above 3%, indicating efficient utilization of assets to generate earnings. However, in the second half of 2022, the ROA turned negative, indicating a decrease in profitability relative to asset utilization.
During the first half of 2023, the negative trend continued but reversed in the second quarter, with the ROA increasing to 3.80%. This positive momentum continued into the following quarters, with the ROA reaching 5.74% by the end of December 2024.
Overall, CONMED Corporation's ROA has shown mixed performance, with periods of both positive and negative returns. It is essential for the company to focus on improving asset efficiency and profitability to sustain and enhance shareholder value in the future.
Peer comparison
Dec 31, 2024